Antitumor activity from antigen-speci fi c CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells

Dimitrios N. Vatakis, Richard C. Koya, Christopher C. Nixon, Liu Wei, Sohn G. Kim, Patricia Avancena, Gregory Bristol, David Baltimore, Donald B. Kohn, Antoni Ribas, Caius G. Radu, Zoran Galic, Jerome A. Zack

Monday, November 28, 2011
Published in PNAS